Skip to main content
Astellas Pharma Inc. (TYO:4503)
Japan flag Japan · Delayed Price · Currency is JPY
1,415.50
-12.50 (-0.88%)
Jun 4, 2025, 3:30 PM JST

Astellas Pharma Revenue

In the fiscal year ending March 31, 2025, Astellas Pharma had annual revenue of 1.91T JPY with 19.25% growth. Astellas Pharma had revenue of 459.29B in the quarter ending March 31, 2025, with 10.78% growth.

Revenue
1,912.32B
Revenue Growth
+19.25%
P/S Ratio
1.34
Revenue / Employee
129.61M
Employees
14,754
Market Cap
2,556.27B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Mar 31, 20251,912.32B308.65B19.25%
Mar 31, 20241,603.67B85.05B5.60%
Mar 31, 20231,518.62B222.46B17.16%
Mar 31, 20221,296.16B46.64B3.73%
Mar 31, 20211,249.53B-51.32B-3.94%
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro
Mar 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Chugai Pharmaceutical 1,222.12B
Daiichi Sankyo Company 1,886.26B
Takeda Pharmaceutical Company 4,581.55B
HOYA Corporation 869.37B
Terumo 1,036.17B
Otsuka Holdings 2,393.18B
Olympus 997.33B
Shionogi & 438.30B
Revenue Rankings

Astellas Pharma News

More News